ArticleBiomedical reports2016

Clinical application of a new warfarin-dosing regimen based on the CYP2C9 and VKORC1 genotypes in atrial fibrillation patients.

Nian-Xin Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.